Avantor, Inc. (AVTR)
| Market Cap | 19.29B |
| Revenue (ttm) | 7.55B |
| Net Income (ttm) | 534.40M |
| Shares Out | 610.34M |
| EPS (ttm) | 0.89 |
| PE Ratio | 35.59 |
| Forward PE | 18.73 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,432,852 |
| Open | 31.30 |
| Previous Close | 31.28 |
| Day's Range | 31.14 - 31.83 |
| 52-Week Range | 28.64 - 44.37 |
| Beta | 1.53 |
| Analysts | Buy |
| Price Target | 41.76 (+32.2%) |
| Earnings Date | Aug 4, 2022 |
About AVTR
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial ... [Read more...]
Financial Performance
In 2021, Avantor's revenue was $7.39 billion, an increase of 15.52% compared to the previous year's $6.39 billion. Earnings were $572.60 million, an increase of 391.08%.
Financial StatementsAnalyst Forecast
According to 25 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is 41.76, which is an increase of 32.15% from the latest price.
News
Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers
Collaboration will support growth of emerging modalities by offering custom cGMP solutions to enhance process efficiency and accelerate speed-to-market RADNOR, Pa. , June 23, 2022 /PRNewswire/ -- Avanto...
Avantor® to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference
RADNOR, Pa. , June 1, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Avantor® Releases 2022 Sustainability Report, Highlighting Significant Progress in Environmental, Social and Governan...
Report outlines work done to date to advance priorities of Avantor's Science for Goodness sustainability platform RADNOR, Pa., May 17, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global p...
Avantor® Announces Conversion of Mandatory Convertible Preferred Stock
RADNOR, Pa. , May 13, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Jonathan Peacock Elected Chairman of the Board of Directors of Avantor®
RADNOR, Pa. , May 12, 2022 /PRNewswire/ -- The board of directors of Avantor, Inc. (NYSE: AVTR) a leading global provider of mission-critical products and services to customers in the life sciences, adv...
Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa. , May 10, 2022 /PRNewswire/ -- Ava...
Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacifi...
SINGAPORE , May 5, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and appli...
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Surpass Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 8.57% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avantor® Reports First Quarter 2022 Results
Net sales of $1.95 billion, increase of 9.2%; organic net sales growth of 5.1% Net income of $190.4 million; Adjusted EBITDA of $423.1 million Diluted GAAP EPS of $0.28; adjusted EPS of $0.38 Operating ...
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
RADNOR, Pa. , April 21, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ...
AVTR vs. PGNY: Which Stock Is the Better Value Option?
AVTR vs. PGNY: Which Stock Is the Better Value Option?
Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022
RADNOR, Pa. , April 6, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and a...
Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum
RADNOR, Pa., March 8, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Avantor® to Participate in Barclays Global Healthcare Conference 2022
RADNOR, Pa., March 1, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Avantor® to Participate in 42nd Annual Cowen Healthcare Conference
RADNOR, Pa., Feb. 25, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Avantor® Announces Planned Retirement of Rajiv Gupta, Board Chairman
RADNOR, Pa., Feb. 15, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Avantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 9.09% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avantor® Reports Fourth Quarter and Full-Year 2021 Results
RADNOR, Pa., Feb. 3, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and app...
Avantor, Inc. (AVTR) Reports Next Week: Wall Street Expects Earnings Growth
Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avantor® to Report Fourth Quarter and Full Year 2021 Results and Host Earnings Call on February 4, 2022
RADNOR, Pa., Jan. 18, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and ap...
Greg Mayer Joins Argosy Healthcare Partners
WAYNE, Pa., Jan. 5, 2022 /PRNewswire/ -- Argosy Healthcare Partners ("AHP"), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversif...
Avantor, Inc. (AVTR) Gains As Market Dips: What You Should Know
In the latest trading session, Avantor, Inc. (AVTR) closed at $42.01, marking a +0.65% move from the previous day.
Avantor, Inc. (AVTR) Gains But Lags Market: What You Should Know
Avantor, Inc. (AVTR) closed the most recent trading day at $41.25, moving +0.36% from the previous trading session.
CORRECTING AND REPLACING: Avantor to Participate in the 40th Annual J.P. Morgan Healthcare Conference
RADNOR, Pa., Dec. 22, 2021 /PRNewswire/ -- In a press release issued under the same headline on December 14, 2021, by Avantor, Inc. (NYSE: AVTR), please note that the presentation time has been updated ...
Avantor (AVTR) to Improve Biopharma Supply Chain With New Site
Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.